Showing results (381-390 of 651) with videos related to

Sort By:
Pageof 66
Neuropsychopharmacology Reports|December 26, 2025
Probiotic Supplementation and Executive Function in Children With Attention-Deficit/Hyperactivity DisorderAbdolrahman Parhiz, Pegah Samani, Majid Kamali, et al.
Neuropsychopharmacology Reports|December 26, 2025
Safety of Vortioxetine in Patients With Depression: A Post-Marketing Surveillance Study of Intracranial Hemorrhage in a Japanese Health Insurance Claims DatabaseTakeshi Inoue, Rie Otake, Tatsuya Hoshino
Neuropsychopharmacology Reports|May 19, 2025
Increased Recall of Negative Memories Following Initial Methylphenidate Administration in a 6-Year-Old Boy With ADHD: A Case ReportQingqing Xiang, Liling Xu, Yanping Feng, et al.
Neuropsychopharmacology Reports|April 23, 2025
Vortioxetine Can Be Used Safely to Treat Depression After Implantable Cardioverter Defibrillator Implantation for Congenital Long QT Syndrome: A Case ReportMakio Yamauchi, Koji Otsuki, Kouhei Sato, et al.
Neuropsychopharmacology Reports|May 2, 2025
Benzodiazepine and Opioid Withdrawal Induced Neuroleptic Malignant Like Syndrome: A Clinical Case Report With Management ComplexitiesBehnam Abbasi, Forouzan Elyasi, Fateme Heydari, et al.
Neuropsychopharmacology Reports|April 25, 2025
Candidate Anxiety-Related Genes in the Hippocampus of Hatano Male Rats: Anxiolytic Action of Neuromedin U in the HippocampusKaito Sato, Atsuhiro Ishii, Shohei Kobayashi, et al.
Neuropsychopharmacology Reports|October 28, 2025
Long-Term Impact of EGUIDE Training on Facility-Wide Guideline Adherence Rate in Schizophrenia and Major Depressive Disorder: A Multicenter StudyNaomi Hasegawa, Hiroyuki Muraoka, Yusuke Arai, et al.
Neuropsychopharmacology Reports|August 15, 2025
Nonrandomized Allocation of Steroid Therapy in Patients With Fukuyama Congenital Muscular Dystrophy: Study Protocol for a Phase II Clinical TrialTerumi Murakami, Takatoshi Sato, Takami Ishizuka, et al.
Neuropsychopharmacology Reports|June 20, 2022
EEG correlates of quality of life and associations with seizure without awareness and depression in patients with epilepsyHideki Azuma, Tatsuo Akechi
Neuropsychopharmacology Reports|June 22, 2022
Oxytocin treatment improves dexamethasone-induced depression-like symptoms associated with enhancement of hippocampal CREB-BDNF signaling in female miceMasayoshi Mori, Hiromi Shizunaga, Hiroyoshi Harada, et al.
Pageof 66